about
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open-Label, Randomized Control StudyAdvances in paediatrics in 2016: current practices and challenges in allergy, autoimmune diseases, cardiology, endocrinology, gastroenterology, infectious diseases, neonatology, nephrology, neurology, nutrition, pulmonology.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Kawasaki disease associated with Mycoplasma pneumoniae
@en
Kawasaki disease associated with Mycoplasma pneumoniae.
@nl
type
label
Kawasaki disease associated with Mycoplasma pneumoniae
@en
Kawasaki disease associated with Mycoplasma pneumoniae.
@nl
prefLabel
Kawasaki disease associated with Mycoplasma pneumoniae
@en
Kawasaki disease associated with Mycoplasma pneumoniae.
@nl
P2093
P2860
P1476
Kawasaki disease associated with Mycoplasma pneumoniae
@en
P2093
Weiguo Qian
Wenhua Yan
Yunjia Tang
P2860
P2888
P356
10.1186/S13052-016-0292-1
P577
2016-09-08T00:00:00Z
P6179
1031442053